ivosidenib,azacitidine
servier
['leukemia', 'myeloid', 'oh2 ', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'aza ', 'agile']
congress | #ash22
hartmut d hner discussed relapse mechanisms in pts with midh1 newly-diangosed #aml receiving ivo + aza. clearance of midh1 and associated remission is seen with ivo + aza treatment but other mutations can emerge to cause relapse.
#medicalcongress 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm